MEDLON B.V.

Name

MEDLON B.V.

Legal name

Medlon B.V.

Website

https://medlon.nl

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

251–500 employees

Ownership category

akta.pro rank

Product category

Medical Laboratory Diagnostics

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro primary industry

Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)

akta.pro secondary industries

Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home) (HSABACAN), Medication Reconciliation & Skilled Medication Administration (Clinical) (HSABACAH), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)

Keywords

• Medical laboratory diagnostics
• Thrombosis care services
• Clinical chemistry testing
• Blood collection services
• Pharmacogenetics testing

Headquarters

HQ city

Enschede

HQ country

Netherlands

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Medical laboratory diagnostics: Medlon provides medical laboratory diagnostic services (clinical chemistry, hematology, DNA testing, etc.) to patients referred by GPs, midwives, specialists, and other healthcare providers. Services are billed through Dutch health insurance under the regulated healthcare tariff framework (NZa). Revenue is generated per test request, with separate order fees and analysis charges.
2. Thrombosis / anticoagulation management: Thrombosis service managing patients on vitamin K antagonists (acenocoumarol, fenprocoumon). Services include INR monitoring, dosing advice, patient self-measurement training, and dosing equipment loans. Billed through health insurance under regulated tariffs. Self-measuring patients are charged per training and control session according to NZa maximum rates.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

Medlon B.V. is a medical diagnostic laboratory providing clinical chemistry, haematology, urinalysis, DNA diagnostics, pharmacogenetics, and Point of Care Testing (POCT) services to healthcare providers in the Twente region of the Netherlands. It also operates a thrombosis (anticoagulation) service managing INR monitoring, dosing advice, and patient self-measurement for patients on vitamin K antagonists. Services are delivered through hospital laboratories at MST and ZGT, regional blood collection points (prikposten), home phlebotomy visits, and electronic ordering/digital patient management systems.

Product overview

Medlon B.V. is a medical diagnostic laboratory organization offering a comprehensive portfolio of diagnostic services and products. The core offerings include medical laboratory diagnostics (blood testing, urine analysis, DNA diagnostics, semen analysis) and thrombosis care (anticoagulation management with INR monitoring and dosing). The company operates Point of Care Testing (POCT) equipment including various meters for glucose, coagulation, CRP, blood gases, and other parameters. Services are delivered through hospital laboratories (MST and ZGT), blood collection points, and home phlebotomy. Medlon also provides educational courses for healthcare professionals and patients on self-measuring techniques. Since April 2018, Medlon has been part of Unilabs, an international medical diagnostics organization.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Laboratory Diagnostics
• Thrombosis Care (Trombosezorg)
• Blood Collection Services
• Home Phlebotomy (Thuisprikken)
• Point of Care Testing (POCT) Managed Service
• Pharmacogenetics Testing
• HLA Typing for Coeliac Disease
• Lactose Intolerance DNA Test
• Malaria Diagnostics (LAMP-PCR)
• NIPT (Non-Invasive Prenatal Testing)
• Holter Diagnostics
• Urine Diagnostics
• Semen Analysis
• Fecal Examination
• Blood Products Storage
• Stem Cell Processing
• Self-Measurement Training (NPT/Zelfmeten)

Quantifiable outcome

• Patient self-measuring reduces in-person clinic visits to once every 3 months after initial training period
• +2 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration11 records

Feature8 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• UnilabscoreStrategic or Co-development Partner · 1 April 2018Since April 2018, Medlon has been part of Unilabs, an international medical diagnostics organisation. This gives Medlon greater possibilities for innovation and research. Medlon is integrated into the Unilabs Netherlands structure alongside Saltro, Hudsonlab, and SHO. The thrombosis service (Unilabs Antistollingszorg) and first-line diagnostics (Unilabs Eerstelijnsdiagnostiek) are delivered under the Unilabs brand.
• SanteoncoreStrategic or Co-development PartnerMedlon BV is the clinical chemistry laboratory of Medisch Spectrum Twente (MST) and belongs to the Santeon laboratory network. Santeon is a nationally operating laboratory network with a combined turnover of over €100M and 750 FTE, consisting of clinical chemistry labs at Canisius-Wilhelmina Ziekenhuis (Nijmegen), OLVG (Amsterdam), St. Antonius Ziekenhuis (Nieuwegein/Utrecht), Catharina Ziekenhuis (Eindhoven), and MST (Enschede/Medlon BV).
• Medisch Spectrum Twente (MST)coreStrategic or Co-development PartnerMedlon originated in 2011 from the fusion of clinical laboratories of ZGT and MST, including the thrombosis services of both hospitals. MST is one of the Santeon hospitals. Medlon is organisationally partly part of MST and operates its laboratory services at the MST site in Enschede.
• Ziekenhuisgroep Twente (ZGT)coreStrategic or Co-development PartnerMedlon provides clinical laboratory services at ZGT hospital locations in Almelo and Hengelo, and has operated the ZGT thrombosis service since 2012. Both thrombosis services (Trombosedienst MST and Trombosedienst ZGT) continue to exist under the Medlon umbrella.
• PortavitacoreTechnology or IntegrationPortavita provides the digital dosing platform used by Medlon's thrombosis service. Patients submit INR readings via the secure Portavita web portal and receive dose recommendations the same day. The platform also manages NPT (self-measuring) for care institutions.
• LabPon (LabMicTa)minorStrategic or Co-development PartnerMedlon participates in regional collaboration with diagnostic providers in Twente, including LabPon / LabMicTa, alongside LabMicTa (regional cooperation with Medlon and Menzis health insurer). Mentioned as a collaboration monitored by the Client Council.
• SHO (now part of Unilabs)minorStrategic or Co-development PartnerSHO and Medlon integrated under the Unilabs Netherlands brand in 2022, following Unilabs' acquisition of SHO. Together they cover blood collection across Twente. SHO handles some specialist testing including rust-ECG (via KSYOS cardiologist reporting).

Scale indicators5 records

Recent moves9 records

Expansion highlights5 records

Regional players

• Streeklaboratorium Haarlem: Streeklaboratorium Haarlem is a regional public Dutch medical microbiology and clinical laboratory serving multiple hospitals in the Kennemerland region. While focused on a different service area, it competes similarly for hospital lab outsourcing contracts in the Dutch hospital laboratory market.

Direct peers

• Atalmedial: Atalmedial is a regional Dutch medical diagnostic laboratory focused on primary care and home-based testing. Officially integrated into Unilabs in November 2023, it directly competes with Medlon in the Dutch first-line diagnostics segment and operates as a sister entity within Unilabs Nederland.
• Result Laboratorium: Result Laboratorium is an independent Dutch clinical chemistry and hematology laboratory operating primarily in the western Netherlands. It competes with Medlon for hospital laboratory outsourcing contracts and offers similar clinical chemistry, hematology, and specialized testing services.
• Saltro: Saltro is a Dutch first-line diagnostics provider serving GPs and primary-care physicians. As a fellow Unilabs Nederland entity alongside Medlon, it competes head-to-head in the same Dutch primary-care referral market with overlapping POCT and electronic ordering capabilities.
• SHO (Centraal Diagnostisch Centrum): SHO provides medical diagnostic services and blood collection throughout the Netherlands. Its Twente operations were integrated with Medlon under Unilabs in July 2022, making it the most direct operational comparator within the same geographic footprint.

Broad incumbents

• Quest Diagnostics: Quest Diagnostics is a leading US-based clinical laboratory network offering routine and specialty diagnostics at significant scale. While geographically distant, its reference-lab and pharmacogenetics offerings mirror Medlon's higher-margin specialty testing ambitions.
• Synlab: Synlab is one of Europe's largest medical diagnostic service providers, offering clinical laboratory testing across multiple countries. As the major continental-scale competitor to Unilabs, it provides relevant benchmarking for scale, lab automation, and service-line breadth in the Dutch market.
• Labcorp (Laboratory Corporation of America): Labcorp is a global clinical laboratory and diagnostics leader. Comparable to Medlon in offering routine chemistry, hematology, and specialty molecular testing, it serves as a strategic reference for portfolio breadth and integrated diagnostics models.
• Sonic Healthcare: Sonic Healthcare is an international diagnostics operator with hospital laboratory and community pathology operations across Australia, Europe (including Germany), and the US. Like Unilabs, it represents a geographically diversified incumbent laboratory platform relevant to Medlon's growth trajectory.

Others

• Eurofins Scientific: Eurofins is a global leader in laboratory testing across food, pharma, environmental, and clinical diagnostics. While broader and not a direct clinical-lab competitor in the Netherlands, it touches clinical/pharmacogenomic testing and represents an adjacent reference for laboratory operating leverage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/medlonbv
• YouTubeyoutube.com/user/medlonbv
• Facebookfacebook.com/medlonbv
• LinkedInlinkedin.com/company/medlon-bv

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MEDLON B.V.